Skip to main content

Table 4 Two-sided Fisher's exact tests for association of CD3 statusa and clinical parameters in the MBTB cohort

From: Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer

  

CD3 low

CD3 high

Pvalue

Age at diagnosis

<50

30

28

0.7442

 

≥50

50

53

 

Tumor size

T1-T2

60

61

1.0000

 

T3

15

15

 

Nodal status

Negative

28

48

0.6128

 

Positive

48

41

 

Grade

1-2

43

19

<0.0001

 

3

31

58

 

Her2 IHC

0-2

46

63

0.0183

 

3

27

15

 

PRb

Negative

63

75

0.0137

 

Positive

17

6

 
  1. aCD3 high, >median level of CD3+ cells per sample; bligand-binding assay; negative, ≤15 fmol/mg protein
Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us